Literature DB >> 7964345

Lung cancer: histological aspects of diagnosis in England and the south east Netherlands.

S M Crawford1, F Atherton.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7964345      PMCID： PMC1059995          DOI： 10.1136/jech.48.4.420

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  3 in total

1.  Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983.

Authors:  C K Connolly; W G Jones; J Thorogood; C Head; M F Muers
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

2.  An audit of the quality of cancer registration data.

Authors:  R Lapham; N R Waugh
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

3.  Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86.

Authors:  S W Watkin; G K Hayhurst; J A Green
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640
  3 in total
  4 in total

Review 1.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

2.  Social and geographical factors affecting access to treatment of lung cancer.

Authors:  S M Crawford; V Sauerzapf; R Haynes; H Zhao; D Forman; A P Jones
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

3.  Lung cancer referral patterns in the former Yorkshire region of the UK.

Authors:  P P Melling; A C Hatfield; M F Muers; M D Peake; C J Storer; C E Round; R A Haward; S M Crawford
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

4.  Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975.

Authors:  M L Janssen-Heijnen; R M Schipper; P J Klinkhamer; M A Crommelin; W J Mooi; J W Coebergh
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.